Phase III Long-Term Extension Study With Dexpramipexole

Clinical trial NCT06388889 · TERMINATED

Trial details

NCT number: NCT06388889
Sponsor: Areteia Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Asthma

Start date: 2024-06-12
Primary completion: 2025-12-08
Enrollment: 509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.